Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Indexed In
- RefSeek
- Hamdard University
- EBSCO A-Z
Useful Links
Share This Page
Dr Diksic Mirko
Dr Diksic Mirko
Professor Emeritus
Department of Neurology and Neurosurgery
McGill University
Montreal
Canada
Biography
Dr. Mirko Diksic is currently working as a Professor in Department of Neurology and Neurosurgery at Mc Gill University, Canada. He did his MSc and PhD from the University of Zagreb, Zagreb, Croatia. He has been been honoured with various scholarships, Membership in Professional Associations. He is a Refree, Research Reviewer, Editorial Board Member for various journals. At Mc Gill University he was Commitee Member of Acting Radiation Safety Officer; MNI/H (1999-2000), Member and Chairman of the Radiation Safety Committee (1979-2010). His major areas of research interest includes: evaluation of the brain serotonergic system in humans using positron emission tomography and in animals using autoradiography, development of new biological models for brain protein synthesis with special emphasis on brain tumors. His publications include 260 papers published in refereed journals, 280 abstracts, 149 invited lectures, and 8 review articles in refereed journals. He is a coeditor of a book.
Research Interest
Development of new biological models for brain protein synthesis with special emphasis on brain tumors, Study of the brain serotonergic and dopaminergic systems in animals and humans, Measurement of brain pathophysiological variables in humans using PET and animals using multi-tracer autoradiography, Development of new synthesis for radiopharmaceuticals labelled with short-lived positron emitting radionuclides.
